Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,421,611 papers from all fields of science
Search
Sign In
Create Free Account
ERBB2 gene
Known as:
erbb2 Genes
, erbB-2 Gene
, Genes, erbB-2
Expand
The erbB-2 gene is a proto-oncogene that codes for the erbB-2 receptor (RECEPTOR, ERBB-2), a protein with structural features similar to the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
48 relations
Adenocarcinoma of lung (disorder)
Atypical Medullary Breast Carcinoma
Breast Carcinoma with Choriocarcinomatous Features
Cell Proliferation
Expand
Broader (1)
Proto-Oncogenes
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer
T. Junttila
,
Guangmin Li
,
Kathryn L. Parsons
,
G. Phillips
,
M. Sliwkowski
Breast Cancer Research and Treatment
2011
Corpus ID: 6241797
Trastuzumab (Herceptin®) is currently used as a treatment for patients whose breast tumors overexpress HER2/ErbB2. Trastuzumab…
Expand
Highly Cited
2006
Highly Cited
2006
Statistical methods for characterizing diversity of microbial communities by analysis of terminal restriction fragment length polymorphisms of 16S rRNA genes.
Z. Abdo
,
Ursel M E Schüette
,
S. Bent
,
Christopher J. Williams
,
L. Forney
,
P. Joyce
Environmental Microbiology
2006
Corpus ID: 25835608
The analysis of terminal restriction fragment length polymorphisms (T-RFLP) of 16S rRNA genes has proven to be a facile means to…
Expand
Highly Cited
2003
Highly Cited
2003
CANON and Anammox in a gas-lift reactor.
A. O. Sliekers
,
K. Third
,
W. Abma
,
J. Kuenen
,
M. Jetten
,
M. Jetten
FEMS Microbiology Letters
2003
Corpus ID: 26782328
Highly Cited
2002
Highly Cited
2002
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites.
D. Gancberg
,
A. Leo
,
+7 authors
D. Larsimont
Annals of Oncology
2002
Corpus ID: 17474124
BACKGROUND The humanized anti-HER-2 monoclonal antibody trastuzumab (Herceptin) is a new treatment modality for metastatic breast…
Expand
Highly Cited
1994
Highly Cited
1994
Identification of c‐erbB‐3 binding sites for phosphatidylinositol 3′‐kinase and SHC using an EGF receptor/c‐erbB‐3 chimera.
S. Prigent
,
W. Gullick
EMBO Journal
1994
Corpus ID: 19974019
c‐erbB‐3 is a member of the type I (EGF receptor‐related) family of growth factor receptors for which no ligand has been…
Expand
Highly Cited
1990
Highly Cited
1990
Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.
J. Camps
,
Shih-Ming Chang
,
+5 authors
L. Chung
Proceedings of the National Academy of Sciences…
1990
Corpus ID: 24187897
Transformed fibroblasts coinoculated with epithelial cells accelerated the growth and shortened the latency period of human…
Expand
Highly Cited
1989
Highly Cited
1989
Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
L. Bouchard
,
L. Lamarre
,
P. Tremblay
,
P. Jolicoeur
Cell
1989
Corpus ID: 19343087
Highly Cited
1989
Highly Cited
1989
Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts
Y. Kokai
,
J. Myers
,
+5 authors
M. Greene
Cell
1989
Corpus ID: 32987764
Highly Cited
1989
Highly Cited
1989
Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.
H. Tsuda
,
S. Hirohashi
,
+7 authors
J. Yokota
Cancer Research
1989
Corpus ID: 3075257
The incidence and association with 10-year survival of amplification in five protooncogenes or transforming genes were…
Expand
Highly Cited
1985
Highly Cited
1985
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
J. Drebin
,
V. C. Link
,
D. Stern
,
R. Weinberg
,
M. Greene
Cell
1985
Corpus ID: 26000048
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE